Researchers at The Ohio State University have developed a groundbreaking blood test that may accurately predict the risk of ...

Beta blockers are go-to meds for many people who've survived a heart attack, but might not be needed for patients whose ...

November 12, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the development and commercialization of a biomarker ...

It took months for Brooke to get diagnosed. She was prescribed antidepressants, but nothing worked. That’s why researchers at ...

The birth of your baby is supposed to be one of the most joyous moments of a new mom’s life, but for one in seven new mothers, it’s a time ...

Postpartum depression, a mental health condition affecting millions of new mothers, may soon be easier to diagnose and treat, ...

Physicians often work for extended hours to provide medical care for patients, which can result in sleep loss and affect their optimal functioning. Researchers from Juntendo University have conducted ...

The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...

Compass Pathways is advancing pivotal trials to test psilocybin's impact on treatment-resistant depression. See why I rate ...

The BDI exhibits strong internal consistency, with studies frequently reporting Cronbach’s alpha coefficients between 0.80 and 0.90, indicating that the individual items on the scale measure the same ...

A third of former NFL players believe they have a chronic brain condition linked to football. A new blood test could help tackle the issue.